Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome
2019-01-01 Pala, L; Nezi, L; De Pas, T; Pennacchioli, E; Cocorocchio, E; Ferrucci, P; Conforti, F; Goldhirsch, A
Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials
2022-01-01 Conforti, F; Pala, L; De Pas, T; He, Yf; Giaccone, G
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
2016-01-01 Alberobello, At; Wang, Ys; Beerkens, Fj; Conforti, F; Mccutcheon, Jn; Rao, Gh; Raffeld, M; Liu, J; Rahhal, R; Zhang, Yw; Giaccone, G
Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study
2022-01-01 Conforti, F; Gronchi, A; Penel, N; Jones, Rl; Broto, Jm; Sala, I; Bagnardi, V; Napolitano, A; Pala, L; Pennacchioli, E; Catania, C; Queirolo, P; Grigani, G; Merlini, A; Stacchiotti, S; Comandone, A; Vincenzi, B; Quagliuolo, V; Bertuzzi, A; Boglione, A; Palassini, E; Baldi, Gg; Blay, Jy; Ryckewaert, T; Toulmonde, M; Italiano, A; Le Cesne, A; Ray-Coquard, I; Cruz, J; Hernandez-Leon, Cn; Trufero, Jm; Moura, Dd; Muniz, Nh; De Pas, T
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
2022-01-01 Corso, Giovanni; D'Ecclesiis, Oriana; Magnoni, Francesca; Mazzotta, Erica; Conforti, Fabio; Veronesi, Paolo; Sajjadi, Elham; Venetis, Konstantinos; Fusco, Nicola; Gandini, Sara
Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations
2022-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Colleoni, M; Buyse, M; Hortobagyi, G; Gianni, L; Winer, E; Loibl, S; Cortes, J; Piccart, M; Wolff, Ac; Viale, G; Gelber, Rd
EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS
2014-01-01 Toffalorio, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Barberis, M; De Marinis, F; De Pas, T
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers
2023-01-01 Zagami, P.; Comandone, A.; Fiore, M.; Giulio Baldi, G.; Grignani, G.; Vincenzi, B.; Gronchi, A.; Antonarelli, G.; Boglione, A.; Pennacchioli, E.; Curigliano, G.; Conforti, F.; De Pas, T. M.
Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors
2017-01-01 Conforti, F; Zhang, X; Rao, Gh; De Pas, T; Yonemori, Y; Rodriguez, Ja; Mccutcheon, Jn; Rahhal, R; Alberobello, At; Wang, Ys; Zhang, Yw; Guha, U; Giaccone, G
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
2019-01-01 Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A.
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
2022-01-01 Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T
Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action
2022-01-01 Pala, L; De Pas, T; Conforti, F
Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center
2024-01-01 Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
2018-01-01 Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors
2020-01-01 Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P
High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study
2023-01-01 Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm
Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling
2015-01-01 Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G
Sex and cancer immunotherapy: Current understanding and challenges
2022-01-01 Pala, Laura; De Pas, Tommaso; Catania, Chiara; Giaccone, Giuseppe; Mantovani, Alberto; Minucci, Saverio; Viale, Giuseppe; Gelber, Richard D; Conforti, Fabio
Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer
2025-01-01 Pala, Laura; De Pas, Tommaso; Cocorocchio, Emilia; Catania, Chiara; Ceresoli, Giovanni; Laszlo, Daniele; Zattarin, Emma; Rossi, Giovanna; Conforti, Fabio
A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy
2018-01-01 Perrino, M; Bozzarelli, S; Zucali, Pa; De Pas, Tm; Simonelli, M; De Vincenzo, F; Conforti, F; Persico, P; Miggiano, C; Cordua, N; Cioffi, A; Sala, S; Sposta, Fm; Giordano, L; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Sex Differences in Efficacy and Toxicity of Systemic Cancer Treatments: Role of the Microbiome | 1-gen-2019 | Pala, L; Nezi, L; De Pas, T; Pennacchioli, E; Cocorocchio, E; Ferrucci, P; Conforti, F; Goldhirsch, A | |
| Investigational drugs for the treatment of thymic cancer: a focus on phase 1 and 2 clinical trials | 1-gen-2022 | Conforti, F; Pala, L; De Pas, T; He, Yf; Giaccone, G | |
| PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors | 1-gen-2016 | Alberobello, At; Wang, Ys; Beerkens, Fj; Conforti, F; Mccutcheon, Jn; Rao, Gh; Raffeld, M; Liu, J; Rahhal, R; Zhang, Yw; Giaccone, G | |
| Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study | 1-gen-2022 | Conforti, F; Gronchi, A; Penel, N; Jones, Rl; Broto, Jm; Sala, I; Bagnardi, V; Napolitano, A; Pala, L; Pennacchioli, E; Catania, C; Queirolo, P; Grigani, G; Merlini, A; Stacchiotti, S; Comandone, A; Vincenzi, B; Quagliuolo, V; Bertuzzi, A; Boglione, A; Palassini, E; Baldi, Gg; Blay, Jy; Ryckewaert, T; Toulmonde, M; Italiano, A; Le Cesne, A; Ray-Coquard, I; Cruz, J; Hernandez-Leon, Cn; Trufero, Jm; Moura, Dd; Muniz, Nh; De Pas, T | |
| Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis | 1-gen-2022 | Corso, Giovanni; D'Ecclesiis, Oriana; Magnoni, Francesca; Mazzotta, Erica; Conforti, Fabio; Veronesi, Paolo; Sajjadi, Elham; Venetis, Konstantinos; Fusco, Nicola; Gandini, Sara | |
| Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer Critical Analysis of Strengths, Weaknesses, and Misinterpretations | 1-gen-2022 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Colleoni, M; Buyse, M; Hortobagyi, G; Gianni, L; Winer, E; Loibl, S; Cortes, J; Piccart, M; Wolff, Ac; Viale, G; Gelber, Rd | |
| EPIDERMAL GROWTH FACTORS TYROSINE-KINASE INHIBITORS (EGFR-TKI) EFFICACY IN NSCLC PATIENTS WITH HIGH POLYSOMY OF CHROMOSOME 7 AND EGFR/KRAS WILD TYPE TUMORS | 1-gen-2014 | Toffalorio, F; Conforti, F; Spitaleri, G; Catania, C; Noberasco, C; Lazzari, C; Barberis, M; De Marinis, F; De Pas, T | |
| The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers | 1-gen-2023 | Zagami, P.; Comandone, A.; Fiore, M.; Giulio Baldi, G.; Grignani, G.; Vincenzi, B.; Gronchi, A.; Antonarelli, G.; Boglione, A.; Pennacchioli, E.; Curigliano, G.; Conforti, F.; De Pas, T. M. | |
| Therapeutic Effects of XPO1 Inhibition in Thymic Epithelial Tumors | 1-gen-2017 | Conforti, F; Zhang, X; Rao, Gh; De Pas, T; Yonemori, Y; Rodriguez, Ja; Mccutcheon, Jn; Rahhal, R; Alberobello, At; Wang, Ys; Zhang, Yw; Guha, U; Giaccone, G | |
| Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis | 1-gen-2019 | Conforti, F.; Pala, L.; Bagnardi, V.; Viale, G.; De Pas, T.; Pagan, E.; Pennacchioli, E.; Cocorocchio, E.; Ferrucci, P. F.; De Marinis, F.; Gelber, R. D.; Goldhirsch, A. | |
| Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy | 1-gen-2022 | Corti, C; Conforti, F; Pala, L; Catania, C; Cocorocchio, E; Ferrucci, Pf; Curigliano, G; Queirolo, P; De Pas, T | |
| Under-representation of women in Randomized Clinical Trials testing anticancer immunotherapy may undermine female patients care. A call to action | 1-gen-2022 | Pala, L; De Pas, T; Conforti, F | |
| Primary malignant phyllodes tumors of the breast: A retrospective analysis from a referral center | 1-gen-2024 | Valenza, Carmine; De Pas, Tommaso Martino; Gaeta, Aurora; Castellano, Grazia; Santoro, Celeste; Corona, Amedeo; Chiappini, Giulia; Vivanet, Grazia; Trapani, Dario; Coppola, Sara; Conforti, Fabio; Mattar, Denise; Gandini, Sara; Veronesi, Paolo; Pennacchioli, Elisabetta; Curigliano, Giuseppe | |
| Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis | 1-gen-2018 | Conforti, F; Pala, L; Bagnardi, V; De Pas, T; Martinetti, M; Viale, G; Gelber, Rd; Goldhirsch, A | |
| Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors | 1-gen-2020 | Cocorocchio, E; Martinoli, C; Gandini, S; Pala, L; Conforti, F; Stucchi, S; Mazzarol, G; Ferrucci, P | |
| High-dose continuous-infusion ifosfamide in advanced thymic epithelial Tumors: A TYME network study | 1-gen-2023 | Conforti, F; Pala, L; Vivanet, G; Corti, C; Catania, C; Maiettini, D; Varano, G; Di Venosa, B; Curigliano, G; Salvini, P; Berardi, R; Ballatore, Z; De Pas, Tm | |
| Molecular Pathways: Anticancer Activity by Inhibition of Nucleocytoplasmic Shuttling | 1-gen-2015 | Conforti, F; Wang, Ys; Rodriguez, Ja; Alberobello, At; Zhang, Yw; Giaccone, G | |
| Sex and cancer immunotherapy: Current understanding and challenges | 1-gen-2022 | Pala, Laura; De Pas, Tommaso; Catania, Chiara; Giaccone, Giuseppe; Mantovani, Alberto; Minucci, Saverio; Viale, Giuseppe; Gelber, Richard D; Conforti, Fabio | |
| Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer | 1-gen-2025 | Pala, Laura; De Pas, Tommaso; Cocorocchio, Emilia; Catania, Chiara; Ceresoli, Giovanni; Laszlo, Daniele; Zattarin, Emma; Rossi, Giovanna; Conforti, Fabio | |
| A phase II study of regorafenib in patients with thymic epithelial tumours previously treated with chemotherapy | 1-gen-2018 | Perrino, M; Bozzarelli, S; Zucali, Pa; De Pas, Tm; Simonelli, M; De Vincenzo, F; Conforti, F; Persico, P; Miggiano, C; Cordua, N; Cioffi, A; Sala, S; Sposta, Fm; Giordano, L; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26842
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269046
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS226
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE181
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19414
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19124
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24589
- reserved1362
- open891